PT - JOURNAL ARTICLE AU - Hsu, Yu-Han H. AU - Nacu, Eugeniu AU - Liu, Ruize AU - Kim, April AU - Tsafou, Kalliopi AU - Petrossian, Natalie AU - Crotty, William AU - Suh, Jung Min AU - Pintacuda, Greta AU - Riseman, Jackson AU - Martin, Jacqueline M. AU - Malolepsza, Edyta AU - Li, Taibo AU - Singh, Tarjinder AU - Ge, Tian AU - Egri, Shawn B. AU - Tanenbaum, Benjamin AU - Stanclift, Caroline R. AU - Apffel, Annie M. AU - Schizophrenia Working Group of the Psychiatric Genomics Consortium, Stanley Global Asia Initiatives AU - Carr, Steven A. AU - Schenone, Monica AU - Jaffe, Jake AU - Fornelos, Nadine AU - Huang, Hailiang AU - Eggan, Kevin C. AU - Lage, Kasper TI - Using brain cell-type-specific protein interactomes to interpret genetic data in schizophrenia AID - 10.1101/2021.10.07.21264568 DP - 2021 Jan 01 TA - medRxiv PG - 2021.10.07.21264568 4099 - http://medrxiv.org/content/early/2021/10/10/2021.10.07.21264568.short 4100 - http://medrxiv.org/content/early/2021/10/10/2021.10.07.21264568.full AB - Genetics have nominated many schizophrenia risk genes that lack functional interpretation. To empower such interpretation, we executed interaction proteomics for six risk genes in human induced neurons and found the resulting protein network to be enriched for common variant risk of schizophrenia in Europeans and East Asians. The network is down-regulated in layer 5/6 cortical neurons of patients and can complement fine-mapping and eQTL data to prioritize additional genes in GWAS loci. A sub-network centered on HCN1 is enriched for common variant risk and also contains proteins (HCN4 and AKAP11) enriched for rare protein-truncating mutations in patients with schizophrenia and bipolar disease. Our findings establish brain cell-type-specific interactomes as an organizing framework to facilitate interpretation of genetic and transcriptomic data in schizophrenia and psychiatric diseases.One Sentence Summary Neuronal protein interactomes is an organizing framework for integrating genetic and transcriptomic data in schizophrenia.Competing Interest StatementKCE is a co-founder of Q-State Biosciences, Quralis, and Enclear, and currently employed at BioMarin Pharmaceutical. All the other authors declare no competing interests.Funding StatementThis work was supported by grants from the Stanley Center for Psychiatric Research, the US National Institute of Mental Health (R01 MH109903 and U01 MH121499), the Simons Foundation Autism Research Initiative (awards 515064 and 735604), the Lundbeck Foundation (R223-2016-721 and R350-2020-963), the US National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK078616 and T32 DK110919), and a Broad Next10 grant.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB approvals for accessing the individual-level GWAS data were obtained from the Psychiatric Genomics Consortium and Stanley Global Asia Initiatives as described in Text S3.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRaw IP-MS data will be available through MassIVE upon publication of the manuscript.